Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer

Background Esophagectomy with three-field lymphadenectomy has been performed for esophageal cancer. Detailed analysis of cause of death and mode of recurrence is required to determine the need for further adjuvant therapy and follow-up. Materials and methods A total of 208 patients who underwent eso...

Full description

Saved in:
Bibliographic Details
Published inLangenbeck's archives of surgery Vol. 395; no. 4; pp. 341 - 346
Main Authors Natsugoe, Shoji, Matsumoto, Masataka, Okumura, Hiroshi, Uchikado, Yasuto, Setoyama, Tetsuro, Sasaki, Ken, Sakurai, Toshihide, Omoto, Itaru, Owaki, Tetsuhiro, Shinchi, Hiroyuki, Ueno, Shinichi, Ishigami, Sumiya
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 01.04.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Esophagectomy with three-field lymphadenectomy has been performed for esophageal cancer. Detailed analysis of cause of death and mode of recurrence is required to determine the need for further adjuvant therapy and follow-up. Materials and methods A total of 208 patients who underwent esophagectomy through right thoracotomy with three-field lymphadenectomy were enrolled into the present study. Mode of first recurrence was divided into four groups: lymph node, hematogenous, mixed, and local recurrence. Results Excluding 16 hospital deaths, the number of deaths and 5-year survival rates were 104 patients and 7.8% for cancer recurrence, 12 patients and 53.8% for second primary cancers in other organs, and 34 patients and 31.0% for causes of death unrelated to carcinoma. In the 104 patients with relapse, 5-year survival rate of patients was 14.3% with lymph node recurrence ( n  = 29), 9.1% with hematogenous recurrence ( n  = 32), 3.1% with mixed recurrence ( n  = 35), and 12.5% with local recurrence ( n  = 8). Conclusion To improve outcomes for esophagectomy with three-field lymphadenectomy, early detection of recurrent disease and regular examination of the entire body for secondary cancer is necessary.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1435-2443
1435-2451
DOI:10.1007/s00423-010-0592-7